Passage:
In economic history, scholars have long debated whether the enactment of the Plant Patent Act of 1930 in the United States—which granted intellectual property protection to inventors of new, asexual plant varieties—actually stimulated private innovation in agricultural biotechnology. Proponents of the statutory incentive view contend that patent protection offered temporary monopoly rents, thereby incentivizing private breeders to invest capital in high-risk breeding programs that had previously been dominated by public agricultural experiment stations. However, recent empirical analyses comparing patenting trends before and after 1930 suggest that the Act did not lead to a statistically significant surge in the overall rate of plant innovation. Critics of the statutory incentive view point out that the cost and complexity of enforcing plant patents initially rendered them weak deterrents against unauthorized propagation by rival firms. Furthermore, because public institutions continued to freely disseminate foundational breeding lines and germplasm to all market participants, private sector investments remained concentrated in incremental, hybrid variations rather than pioneering breakthroughs. Consequently, these researchers argue that the primary catalyst for private sector entry into agricultural biotechnology was not the legally enforceable patent rights created by the 1930 legislation, but rather the rapid expansion of hybrid seed technology, which possessed an inherent biological barrier against unauthorized reproduction.
Statement: Based on the passage, if historical evidence demonstrated that private sector investment in non-hybrid crops surged dramatically immediately following the simplification of patent enforcement mechanisms in the late 1940s, this finding would weaken the passage's argument that hybrid seed technology was the primary catalyst for private sector entry into agricultural biotechnology.
Answer: Answer